Principal Investigalof/Progfam Director (Last, first, middle): 
Champlla Richard E. 
9. 
O 
liJiO 
< 
O 
Qll. 
Z 
— 12 . 
C/) 
z 
GC 
<14. 
s 
z'" 
XI6. 
K 
^18. 
C/5 
lUl9. 
o 
< 
CL20. 
Z 
g 
D 
Z 
F 
z 
o 
o 
Champlin RE . Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W. Post-rc 
chemotherapy for adults with acute myelogenous leukemia: improved survival with hi 
cytarabine/daunorubicin consolidation treatment. J Clin Oncol 1990; 8:1199-1206. 
Champlin RE . Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M, Holley G, Yam P, 
Winston DJ, et al. Bone marrow transplantation for severe aplastic anemia. Effect of a pre 
regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cycloi 
methotrexate therapy. Transplantation 1990; 49:720-724. 
Champlin RE . Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, } 
T. Retention of graft-versus-host-leukemia using selective depletion of CDS-positive-T-lyrop 
for prevention of graft-versus-host disease following bone marrow transplantation for 
myelogenous leukemia. Transplant Proc, 1991; 23:1695-1696. 
Champlin RE . Therapeutic use of hematopoietic growth factors in bone marrow transplantation. 
Bulletin, 1991; 43:197-207. 
Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE . Forman SJ, Koyal D, Walk 
Amplification by the polymerase chain reaction of hypervariable regions of the human gen-' 
evaluation of chimerism after bone marrow transplantation. Blood 1991; 77:1607-1615. 
Nimer SD, Golde DW, Kwan K, Lee K, Clark S, Champlin RE . In vitro production of gram 
macrophage colony-stimulating factor in aplastic anemia: Possible mechanisms of ac 
antithymocyte globulin. Blood 1991; 78:163-168. 
Champlin RE . Immunobiology of bpne marrow transplantation as treatment for hem 
malignancies. Transplant Proc 1991; 43:197-207. 
Storb R and Champlin RE . Bone marrow transplantation for severe aplastic anemia. Bone 
Transplantation 1991; 8:69-72. 
Champlin RE . Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone 
transplantation. Semin Hematol 1992; 29:46-52. 
Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin RE . A randomized s 
intermediate versus conventional dose cytarabine as induction chemotherapy for acute myel* 
leukemia. Br J Hematol, 1992;in press. 
Gluckman E, Horowitz M, Champlin R . Hows J, Bacigalupo A, Biggs J, Camitta B, Gale R, C 
Smith E, Marmont A, Masaoka T, Ramsay N, Rimm A, Rozman C, Sobocinski Km Speck B, B( 
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-vers 
disease prophylaxis regimens on outcome. Blood 1992;79:269-275. 
Horowitz M, Przepiorka D, Champlin RE . Gale RP, Gratwohl A, Herzig RH, Prentice HG, Rin 
Ringden O, Bortin M. Should HLA-Identical sibling bone marrow transplants for leukemia be re 
to large centers? Blood 1992; 79:2771-2774. 
Lee M, Khouri I, Champlin RE . Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth / 
S. Detection of minimal residual leukemia by polymerase chain reaction of the bcr/abl transc 
Philadelphia positive chronic myelogenous leukemia following allogeneic bone marrow transplai 
Brit J Hematol 1992:(in press) 
1546) 
Recombinant DNA Research, Volume 19 
